Dieter Weinand Named to Head Bayer HealthCare Pharmaceuticals

Effective August 1, 2014, Dieter Weinand will become president of Bayer HealthCare Pharmaceuticals and at the same time join the Executive Committee of Bayer HealthCare. He replaces Andreas Fibig, who will leave Bayer on September 1, 2014, to become CEO of International Flavours and Fragrances.

The 53-year-old native of Boppard, Germany is currently president global commercialization & Portfolio management at Otsuka Pharmaceutical Development & Commercialization, Princeton, New Jersey, USA. He has more than 25 years of experience in various commercial operative and strategic executive roles in the pharmaceutical industry, including stints at Pfizer and Bristol-Myers Squibb.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read